Alan F. Denenberg

Davis Polk is advising JP Morgan as financial adviser to Teleflex Incorporated in connection with its approximately $1 billion acquisition of Vascular Solutions, Inc. The closing of the…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the $107 million initial public offering by Quantenna Communications, Inc. of 6,700,000…

Davis Polk advised the joint book-running managers in connection with a $100.1 million SEC-registered offering of 3,850,000 ordinary shares of Theravance Biopharma, Inc. The ordinary…

Davis Polk advised the joint book-running managers and representatives of the several underwriters on the initial public offering by iRhythm Technologies, Inc. iRhythm sold 7,238,235 shares…

Davis Polk advised the representatives of the underwriters in connection with an SEC-registered notes offering by NIKE, Inc., consisting of $1 billion aggregate principal amount of its 2…

Davis Polk is advising Qatalyst Partners as financial adviser to Everyday Health, Inc. in connection with its $465 million acquisition by Ziff Davis, LLC, which comprises the Digital Media…

Davis Polk advised the bookrunners in connection with the $93 million public offering of common stock by Callidus Software Inc. The common stock is listed on the NASDAQ Global Market under…

Davis Polk advised the joint book-running managers on a $6.25 billion SEC-registered debt offering by Cisco Systems, Inc., consisting of $500 million of floating-rate notes due September 20…

Davis Polk advised the joint book-running managers on the SEC-registered offering by NVIDIA Corporation of $1 billion aggregate principal amount of 2.20% notes due 2021 and $1 billion…

Davis Polk is advising J.P. Morgan Securities as financial adviser to Medivation, Inc. in connection with its approximately $14 billion acquisition by Pfizer Inc. The acquisition, which is…